Gene · 1195
Papers1,704
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,704
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mesoscale proximity labeling at chromatin leads to identification of small molecule mechanism of action. | Nat Commun | 2026 | 42773171 | PubTator, text mining | PubMed |
| Decoding the off-target potency of DB18: A comparative structural study of CLK1 and TRK kinases. | Comput Biol Chem | 2026 | 42748630 | PubTator, text mining | PubMed |
| A recurrently perturbed 12-gene program marks drug-tolerant persister states across cancer types. | Front Bioinform | 2026 | 42682804 | PubTator, text mining | PubMed |
| Thermo-sensing mechanisms of splicing control by nuclear stress bodies. | Mol Cell | 2026 | 42462707 | PubTator, text mining | PubMed |
| PERK orchestrates an endoplasmic reticulum stress alternative splicing program via CLK1/SRSF1. | Nat Commun | 2026 | 42321166 | PubTator, text mining | PubMed |
| Comprehensive proteogenomic characterization reveals clinically relevant molecular subtypes associated with medulloblastoma progression. | Exp Mol Med | 2026 | 42249086 | PubTator, text mining | PubMed |
| Differential Host Gene Expression Associated with Non-Lactobacillus-dominant Vaginal Microbiomes During Pregnancy. | Res Sq | 2026 | 42245806 | PubTator, text mining | PubMed |
| Identification of novel CLK1 inhibitors by computational fragment-based ligand design, co-crystallization, chemical synthesis and structure activity relationships. | Eur J Med Chem | 2026 | 42176653 | PubTator, text mining | PubMed |
| Phase I Study of Rogocekib in Patients with Advanced, Relapsed, or Refractory Malignant Solid Tumors. | Clin Cancer Res | 2026 | 42148878 | PubTator, text mining | PubMed |
| Phosphoproteomic and kinase networks reveal partial EMT and stress-adaptive growth programs in pediatric Peutz-Jeghers polyps. | Pediatr Res | 2026 | 42082734 | PubTator, text mining | PubMed |
| Hormone-modulated transcription factors orchestrating the root nodule symbiosis. | Front Plant Sci | 2026 | 42064303 | PubTator, text mining | PubMed |
| Differential phosphorylation of PHIP phosphopeptides with implications in insulin signaling. | BMC Mol Cell Biol | 2026 | 42056878 | PubTator, text mining | PubMed |
| Aging-associated decline of phosphatidylcholine synthesis is a malleable trigger of natural mitochondrial aging. | Nat Commun | 2026 | 42000749 | PubTator, text mining | PubMed |
| Nuclear speckle dynamics are controlled by polyphosphate inhibition of CLK proteins. | Nucleic Acids Res | 2026 | 41978265 | PubTator, text mining | PubMed |
| [Expression, Prognostic and Functional Analysis of SRSF Family Proteins in Non-small Cell Lung Cancer]. | Zhongguo Fei Ai Za Zhi | 2026 | 41916911 | PubTator, text mining | PubMed |
| Alternative splicing in pediatric central nervous system tumors highlights oncofetal candidate CLK1 exon 4. | Neurooncol Pediatr | 2026 | 41908886 | PubTator, text mining | PubMed |
| Dual Inhibition of GSK3 and JAK by BIO Suppresses Osteoblast Differentiation and Mineralization of Human Mesenchymal Cells. | Curr Issues Mol Biol | 2026 | 41899466 | PubTator, text mining | PubMed |
| Chemical programming of kinase inhibitors in a modular chemputer-based system. | Commun Biol | 2026 | 41896327 | PubTator, text mining | PubMed |
| Benzothiazole-Based Anti-Alzheimer's Agents: A Comprehensive Review of Developments from 2015 to 2025. | Chem Rec | 2026 | 41885129 | PubTator, text mining | PubMed |
| Dynamic Switching of Apoptosis-Modulating Bim Heterodimers in Response to BH3 Mimetics in Xenograft Models of Hematologic Malignancies. | Mol Cancer Ther | 2026 | 41841399 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1195/papers